Crosslink Capital’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-696,744
Closed -$11.1M 24
2025
Q2
$11.1M Sell
696,744
-1,532,495
-69% -$27.3M 0.63% 20
2025
Q1
$43.3M Sell
2,229,239
-792,951
-26% -$16.7M 6.74% 6
2024
Q4
$66.6M Sell
3,022,190
-464,755
-13% -$8.95M 9.26% 3
2024
Q3
$58.7M Sell
3,486,945
-99,480
-3% -$1.48M 7.89% 3
2024
Q2
$42.9M Sell
3,586,425
-8,632
-0.2% -$96.4K 5.98% 7
2024
Q1
$39.8M Buy
3,595,057
+354,577
+11% +$3.62M 5.67% 9
2023
Q4
$28.1M Buy
3,240,480
+44,520
+1% +$346K 4.17% 11
2023
Q3
$24.4M Sell
3,195,960
-11,809
-0.4% -$88.6K 4.61% 10
2023
Q2
$23.1M Buy
3,207,769
+194,194
+6% +$1.13M 3.82% 12
2023
Q1
$18.4M Buy
3,013,575
+9,923
+0.3% +$53.8K 3.73% 14
2022
Q4
$13.1M Buy
3,003,652
+119,001
+4% +$532K 3.16% 16
2022
Q3
$11.3M Buy
2,884,651
+682,312
+31% +$3.42M 2.89% 13
2022
Q2
$11.2M Buy
2,202,339
+68,612
+3% +$357K 3.25% 14
2022
Q1
$13.7M Buy
2,133,727
+116,105
+6% +$770K 2.57% 15
2021
Q4
$16.2M Sell
2,017,622
-188,220
-9% -$1.77M 2.56% 13
2021
Q3
$20.4M Buy
+2,205,842
New +$23.1M 3.69% 10

Other funds holding CLBT